Skip To Main Content
Mimetas B.V on Muck Rack

Mimetas B.V

As seen in: Frontiers, Royal Society of Chemistry, BioRxiv
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Mimetas

Contact Mimetas, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Microfluidic artery-on-a-chip model with unidirectional gravity-driven flow for high-throughput applications

|
By H. Ehlers, Mimetas B.V, T. Olivier, S. J. Trietsch
| Royal Society of Chemistry Verified
Microfluidic artery-on-a-chip model with unidirectional gravity-driven flow for high-throughput applications† Cardiovascular disease (CVD) is the leading cause of death worldwide, with a noticeable decline in the approval of new therapeutic interventions. Currently, there is no gold standard for developing new therapies for CVDs, and preclinical models do not translate to clinical efficacy. Therefore, there is an urgent need for in vitro models that more accurately mimic human disease processes.
Open in Who Shared Issue with article?

Breaking barriers: the fungal toxin candidalysin disrupts epithelial integrity and induces inflammation in a gut-on-chip model

|
By Moran Morelli, Karla Queiroz, Mimetas BV, Mimetas B.V
| BioRxiv
Abstract Candida albicans is an opportunistic pathogenic yeast commonly found in the gastrointestinal tract, vagina, and mouth of healthy humans. Under certain conditions, it can become invasive, causing mucosal or life-threatening systemic infections. One mechanism used by C.albicans to breach the epithelial barrier is the secretion of candidalysin, a cytolytic peptide toxin.
Open in Who Shared Issue with article?

Mycotoxin candidalysin impairs epithelial barrier integrity and initiates inflammation in a gut-on-chip model

|
By Moran Morelli, Karla Queiroz, Mimetas BV, Mimetas B.V
| BioRxiv
Abstract Candida albicans is an opportunistic pathogenic yeast commonly found in the gastrointestinal tract, vagina, and oral cavity of healthy humans. Under certain conditions, it can become invasive, causing mucosal or life-threatening systemic infections. One mechanism used by C.albicans to breach the epithelial barrier is the secretion of candidalysin, a cytolytic peptide toxin.
Open in Who Shared Issue with article?
See all 6 articles